Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor

被引:0
|
作者
Darrin Morrissey
Joe O'Connell
Deirdre Lynch
Gerald C. O'Sullivan
Fergus Shanahan
J. Kevin Collins
机构
[1] Departments of Microbiology,
关键词
antisense treatment; human esophageal carcinoma cell lines; invasion; urokinase; urokinase receptor.;
D O I
10.1023/A:1026470417680
中图分类号
学科分类号
摘要
Early metastasis contributes to the very poor prognosis of esophageal carcinoma. The recent immunohistochemical finding that invasive esophageal carcinomas express elevated levels of urokinase (uPA) and urokinase receptor (uPA-R) in vivo suggest that the plasminogen activation system may contribute to metastasis in esophageal cancer. The aim of our study was to functionally investigate, at the molecular level, the relative contribution of uPA and uPA-R to the invasiveness of esophageal cancer cells in vitro. The three esophageal cancer cell lines, OC1-3, generated in our laboratory, were analyzed for uPA and uPA-R expression by RT-PCR, immunoenzymatic staining, and quantitative ELISA. Invasiveness of all cell lines was quantified as percentage cellular invasiveness in a standardized Matrigel in vitro assay. OC1 and OC3, which were found to coexpress both uPA and uPA-R, displayed stronger invasiveness (44% and 32.5% respectively) relative to OC2 (19%) which expressed uPA-R but was negative for uPA. Transfection of OC2 cells with the uPA cDNA resulted in two variants, OC2.uPA1 and OC2.uPA2, stably expressing functional uPA. Both transfectants exhibited enhanced invasiveness (60% and 50% respectively) relative to the parent uPA-negative OC2 cells (19%). Antisense oligonucleotide inhibition of either uPA or uPA-R expression resulted in a similar, marked reduction in invasiveness of esophageal tumor cells which normally coexpress both molecules (OC1, OC3 and the uPA-expressing OC2-transfectant clones). Neither antisense treatment altered the basal invasiveness of OC2, which expresses uPA-R but not uPA. In conclusion, coexpression of uPA with its receptor, uPA-R, is required for functional involvement of the urokinase system in invasion by esophageal carcinoma cells. Our results suggest that these synergistic mediators of invasiveness are quantitatively major contributors to the invasiveness of esophageal carcinoma.
引用
收藏
页码:87 / 95
页数:8
相关论文
共 50 条
  • [21] Modulators of the urokinase-type plasminogen activation system for cancer
    Rosenberg, S
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (12) : 1843 - 1852
  • [22] Cell invasion is affected by differential expression of the urokinase plasminogen activated/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients
    Fibbi, G
    Barletta, E
    Dini, G
    Del Rosso, A
    Pucci, M
    Cerletti, M
    Del Rosso, M
    LABORATORY INVESTIGATION, 2001, 81 (01) : 27 - 39
  • [23] The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors
    Rossi, Francesca Wanda
    Prevete, Nella
    Rivellese, Felice
    Napolitano, Filomena
    Montuori, Nunzia
    Postiglione, Loredana
    Selleri, Carmine
    de Paulis, Amato
    TRANSLATIONAL MEDICINE AT UNISA, 2016, 15 : 34 - 41
  • [24] Urokinase plasminogen activator receptor in breast cancer
    Brunner, N
    HolstHansen, C
    Pedersen, AN
    Pyke, C
    HoyerHansen, G
    Foekens, J
    Stephens, RW
    BREAST CANCER - ADVANCES IN BIOLOGY AND THERAPEUTICS, 1996, : 201 - 207
  • [25] Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells
    Pamarthi M. Mohan
    Sajani S. Lakka
    Sanjeeva Mohanam
    Yoshiaki Kin
    Raymond Sawaya
    Anthanassios P. Kyritsis
    Garth L. Nicolson
    Jasti S. Rao
    Clinical & Experimental Metastasis, 1999, 17 : 617 - 621
  • [26] Increased invasion of neuroglioma cells transfected with urokinase plasminogen activator receptor cDNA
    Mohanam, S
    Chintala, SK
    Mohan, PM
    Sawaya, R
    Lagos, GK
    Gokaslan, ZL
    Kouraklis, GP
    Rao, JS
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (06) : 1285 - 1290
  • [27] Invasiveness of esophageal carcinoma cells requires co-expression of urokinase and urokinase receptor
    Morrissey, D
    OConnell, J
    OSullivan, GC
    Shanahan, F
    Collins, JK
    GASTROENTEROLOGY, 1997, 112 (04) : A619 - A619
  • [28] The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
    Tucker, Torry A.
    Idell, Steven
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 14
  • [29] Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells
    Mohan, PM
    Lakka, SS
    Mohanam, S
    Kin, Y
    Sawaya, R
    Kyritsis, AP
    Nicolson, GL
    Rao, JS
    CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (07) : 617 - 621
  • [30] Targeting the Urokinase Plasminogen Activator Receptor (uPAR)/Urokinase Plasminogen Activator (uPA) System in Acute Myeloid Leukemia
    Mroz, Pawel
    Kosciuczuk, Ewa
    Mazan, Andrew
    Platanias, Leonidas
    MODERN PATHOLOGY, 2015, 28 : 366A - 366A